Clostridium butyricum A powerful probiotic species stimulated by specific prebiotics, Clostridium butyricum produces butyrate, a short-chain fatty acid crucial for gut health
Preclinical risk based on known effects: a Mendelian randomization study of cohorts and large consortia established increased risk of coronary artery disease with increased intake of L-carnitine (Zhao 2022)
A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist
By suppressing appetite and enhancing feelings of fullness, semaglutide GLP-1 can significantly reduce caloric intake and promote weight loss
Common side effects of GLP-1 medications The most commonly reported side effects associated with GLP-1 receptor agonists in clinical literature include nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Most people don't even realise how many problems actually trace back to B12 deficiency
